Literature DB >> 7796493

Familial hypertrophic cardiomyopathy. Nonsense versus missense mutations.

K Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7796493     DOI： 10.1161/01.cir.91.12.2865

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Authors:  Mirco Müller; Antonina Joanna Mazur; Elmar Behrmann; Ralph P Diensthuber; Michael B Radke; Zheng Qu; Christoph Littwitz; Stefan Raunser; Cora-Ann Schoenenberger; Dietmar J Manstein; Hans Georg Mannherz
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

2.  Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.

Authors:  H Watkins; C E Seidman; J G Seidman; H S Feng; H L Sweeney
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

3.  A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.

Authors:  Q Yang; A Sanbe; H Osinska; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 4.  [Clinical picture and therapy of hypertrophic cardiomyopathy].

Authors:  U Gleichmann; H Seggewiss
Journal:  Med Klin (Munich)       Date:  1998-04-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.